Literature DB >> 23946596

Skp2-RNAi suppresses proliferation and migration of gallbladder carcinoma cells by enhancing p27 expression.

Bin Zhang1, Lin-Hua Ji, Wei Liu, Gang Zhao, Zhi-Yong Wu.   

Abstract

AIM: To explore the role of S-phase kinase-associated protein-2 (Skp2) in gallbladder carcinoma and to identify whether depletion of Skp2 by Skp2-RNAi could attenuate proliferation and migration of gallbladder carcinoma.
METHODS: Skp2-RNAi was transduced into cells of the gallbladder carcinoma cell line GBC-SD, using a lentiviral vector. The effect of Skp2-RNAi on the proliferation, migration, invasion and cell cycle of GBC-SD cells was studied using in vitro assays for cell proliferation, colony formation, wound healing and cell cycle. The expression of Skp2 and p27 was detected by real-time polymerase chain reaction and Western immunoblotting. The effect of Skp2-RNAi on the proliferation of GBC-SD cells in vivo was investigated by tumorigenicity experiments in nude mice.
RESULTS: Lentivirus-mediated RNAi reduced the expression of Skp2 in cultured cells. The expression of the p27 protein increased along with the down-regulation of Skp2, although no significant difference was found in p27 mRNA expression. Flow cytometry revealed that Skp2-RNAi transfection significantly increased the proportion of cells in the S phase and significantly decreased the proportion of cells in the G2/M phase. No significant difference in the frequency of cells in the G0/G1 phase was observed. The results from the cell proliferation, colony formation and wound healing assays revealed that Skp2-RNAi transfection markedly inhibited the proliferation and migration of GBC-SD cells in vitro. Additionally, tumorigenicity experiments showed that suppression of Skp2 significantly decreased the weights of the tumors (0.56 ± 0.11 and 0.55 ± 0.07 g in the control and Scr-RNAi groups vs 0.37 ± 0.09 and 0.35 ± 0.08 g in the Skp2-RNAi-L and Skp2-RNAi-H groups).
CONCLUSION: The expression of Skp2 in GBC-SD cells was inhibited following Skp2-RNAi transfection. Silencing of the Skp2 gene inhibited proliferation, migration and invasiveness of GBC-SD cells by mechanisms dependent on enhanced expression of the p27 protein.

Entities:  

Keywords:  Cell cycle; Gallbladder carcinoma; Gene therapy; S-phase kinase-associated protein-2; p27

Mesh:

Substances:

Year:  2013        PMID: 23946596      PMCID: PMC3740421          DOI: 10.3748/wjg.v19.i30.4917

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

1.  The value of EZH2, p27(kip1), BMI-1 and MIB-1 on biopsy specimens with low-risk prostate cancer in selecting men with significant prostate cancer at prostatectomy.

Authors:  Tineke Wolters; Kees J Vissers; Chris H Bangma; Fritz H Schröder; Geert J L H van Leenders
Journal:  BJU Int       Date:  2009-11-03       Impact factor: 5.588

Review 2.  Regulation of Skp2 expression and activity and its role in cancer progression.

Authors:  Chia-Hsin Chan; Szu-Wei Lee; Jing Wang; Hui-Kuan Lin
Journal:  ScientificWorldJournal       Date:  2010-06-01

Review 3.  High p27 expression is associated with a better prognosis in East Asian non-small cell lung cancer patients.

Authors:  Yi Zhuang; Hai-Tao Yin; Xia-Li Yin; Jing Wang; De-Ping Zhang
Journal:  Clin Chim Acta       Date:  2011-08-22       Impact factor: 3.786

4.  The SKP2 E3 ligase regulates basal homeostasis and stress-induced regeneration of HSCs.

Authors:  Sonia Rodriguez; Lin Wang; Christen Mumaw; Edward F Srour; Cristina Lo Celso; Kei-ichi Nakayama; Nadia Carlesso
Journal:  Blood       Date:  2011-04-18       Impact factor: 22.113

Review 5.  The function of p27 KIP1 during tumor development.

Authors:  Jinhwa Lee; Sung Soo Kim
Journal:  Exp Mol Med       Date:  2009-11-30       Impact factor: 8.718

6.  Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells.

Authors:  Wen-Chun Hung; Wei-Lung Tseng; Jentaie Shiea; Hui-Chiu Chang
Journal:  Cancer Lett       Date:  2009-07-21       Impact factor: 8.679

7.  Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.

Authors:  Nozomi Hashimoto; Shinichi Yachida; Keiichi Okano; Hisao Wakabayashi; Katsumi Imaida; Kazutaka Kurokohchi; Tsutomu Masaki; Hisoka Kinoshita; Masahiro Tominaga; Tetsuo Ajiki; Yonson Ku; Takehiro Okabayashi; Kazuhiro Hanazaki; Makoto Hiroi; Sadanobu Izumi; Shohei Mano; Setsuo Okada; Yukihiko Karasawa; Takashi Maeba; Yasuyuki Suzuki
Journal:  Ann Surg Oncol       Date:  2008-11-26       Impact factor: 5.344

8.  Inverse correlation between Skp2 and p27(Kip1) in normal endometrium and endometrial carcinoma.

Authors:  Tsutomu Miyamoto; Akiko Horiuchi; Hiroyasu Kashima; Akihisa Suzuki; Tomoko Yamada; Miyuki Kurai; Ikuo Konishi; Tanri Shiozawa
Journal:  Gynecol Endocrinol       Date:  2010-03       Impact factor: 2.260

9.  Overexpression of adenovirus-mediated p27kip1 lacking the Jab1-binding region enhances cytotoxicity and inhibits xenografted human cholangiocarcinoma growth.

Authors:  Satoru Shiraso; Yu Katayose; Kuniharu Yamamoto; Masamichi Mizuma; Shinichi Yabuuchi; Akira Oda; Toshiki Rikiyama; Tohru Onogawa; Hiroshi Yoshida; Hiroki Hayashi; Hideo Ohtsuka; Fuyuhiko Motoi; Shinichi Egawa; Junya Kato; Michiaki Unno
Journal:  Anticancer Res       Date:  2009-06       Impact factor: 2.480

Review 10.  p27(Kip1) as a prognostic factor in breast cancer: a systematic review and meta-analysis.

Authors:  Xiaoxiang Guan; Yucai Wang; Ruilian Xie; Longbang Chen; Jianling Bai; Jia Lu; Macus Tien Kuo
Journal:  J Cell Mol Med       Date:  2010-02-27       Impact factor: 5.310

View more
  2 in total

Review 1.  MYC Modulation around the CDK2/p27/SKP2 Axis.

Authors:  Per Hydbring; Alina Castell; Lars-Gunnar Larsson
Journal:  Genes (Basel)       Date:  2017-06-30       Impact factor: 4.096

2.  SIAH ubiquitin ligases regulate breast cancer cell migration and invasion independent of the oxygen status.

Authors:  M Gordian Adam; Sonja Matt; Sven Christian; Holger Hess-Stumpp; Andrea Haegebarth; Thomas G Hofmann; Carolyn Algire
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.